XML 51 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Option Activity and Related Information
A summary of the Company’s stock option activity under the Plans is as follows:
 
Shares
 
Weighted-
average exercise
price per share
 
Weighted-
average remaining
contractual
term (in years)
 
Aggregate
intrinsic value
(in thousands)
Outstanding at January 1,2017
4,721,941

 
$
12.00

 
7.41
 
$
48,670

Granted
1,180,086

 
17.90

 
 
 
 
Canceled and forfeited
(478,078
)
 
15.90

 
 
 
 
Exercised
(227,696
)
 
4.78

 
 
 
 
Outstanding at December 31, 2017
5,196,253

 
$
13.32

 
6.98
 
$
3,861

 
 
 
 
 
 
 
 
December 31, 2017:
 
 
 
 
 
 
 
Options vested and expected to vest
4,792,694

 
$
13.07

 
6.84
 
$
3,861

Options exercisable
3,437,421

 
$
11.90

 
6.19
 
$
3,861

Company's Options Outstanding
The following table summarizes information about the Company’s stock options outstanding at December 31, 2017: 
 
Outstanding
 
Exercisable
Exercise Price
Number of
Shares
 
Weighted-
Average
Remaining
Contractual
Life in Years
 
Number of
Shares
 
Weighted-
Average
Remaining
Contractual
Life in Years
$1.92
431,345

 
4.21
 
431,345

 
4.21
$2.24 – $6.72
494,155

 
3.87
 
494,155

 
3.87
$7.47 – $12.56
480,694

 
6.76
 
384,717

 
6.28
$12.77
674,356

 
7.06
 
488,124

 
7.04
$12.94
577,212

 
8.05
 
276,718

 
7.99
$13.01 – $14.95
360,230

 
7.62
 
241,553

 
7.42
$14.99 – $17.50
531,282

 
8.27
 
218,634

 
7.36
$17.89 – $18.90
1,346,556

 
7.63
 
806,525

 
6.66
$19.09 – $22.71
300,423

 
8.22
 
95,650

 
7.33
 
5,196,253




3,437,421

 
 
Restricted Stock Units Award Activity
A summary of RSU activity under the Plans is as follows:
Non-vested RSUs
 
Share Equivalent
 
Weighted-Average Grant Date Fair Value
Non-vested at January 1, 2017
 
163,602

 
$
15.70

Changes during the year:
 
 
 
 
Granted
 
603,493

 
10.73

Vested
 
(66,956
)
 
15.77

Forfeited
 
(38,432
)
 
17.20

Non-vested at December 31, 2017
 
661,707

 
$
11.07

Stock Compensation Expense
The following table sets forth stock-based compensation expense related to stock-based arrangements under the Plans for the years ended December 31 as follows (in thousands):
 
2017
 
2016
 
2015
Cost of revenue
$
719

 
$
548

 
$
471

Research and development
2,853

 
2,046

 
1,453

Selling, general and administrative
7,047

 
5,602

 
3,919

Total stock-based compensation expense
$
10,619


$
8,196


$
5,843

Fair Value of Employee Option Grant
The fair value of each employee option grant as of December 31 was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions:
 
2017
 
2016
 
2015
Risk-free interest rates
1.40% - 2.26%
 
1.18% - 2.12%
 
1.37% - 1.97%
Expected term (years)
5.50 - 6.25
 
5.50 - 6.50
 
6.25
Expected dividend yield
 
 
Expected volatility
53.9% - 58.0%
 
47.0%
 
57.0%